Disclosure: This article does not represent investment advice. The content and materials presented on this page are for educational purposes only.
Milei Moneda (MEDA)’s fixed profits attract INJ and Cardano investors into ongoing pre-sale.
Injective continues to battle the bearish trend, with INJ losing money on monthly and weekly returns. Cardano’s RSI and recent performance give investors the benefit of the doubt.
Some of the top altcoins in the cryptocurrency market have been underperforming for several weeks, most notably Injective (INJ) and Cardano (ADA).
INJ and ADA investors are becoming increasingly frustrated with the downward trend of both coins on the price charts and are now flocking to Milei Moneda (MEDA), a new cryptocurrency ICO that has made it to the list of best 100% guaranteed ICOs. ROI.
Investors sell INJ amid continued decline
Following Injective’s testnet implementation, Injective recently announced the release of the Ionic upgrade to the Injective bridge, according to reports from various cryptocurrency news outlets. The upgrade will allow INJ users to easily move between different blockchains.
Clearly, the Ionic upgrade has established Injective as one of the best DeFi projects in the cryptocurrency world. But the story isn’t quite the same as INJ’s price chart.
INJ has been moving at a snail’s pace over the past few weeks. The coin has seen a price drop of just under 10% compared to last week and is currently trading at 15.97% lower than a month ago. INJ investors are unimpressed by INJ’s decline and are now locked in for big profits from other projects.
Cardano: Not Showing Optimistic Promise
ADA is one of the top 10 altcoins by market capitalization, while Cardano has experienced some growth in Total Value Locked (TVL). However, the increased interest in Cardano has not translated into substantial growth in ADA investor portfolios.
Cardano has struggled to break out of the downward trend over the past few days. ADA has maintained a 9.25% decline since last week and is currently down a slight 1.6% YTD.
While ADA remains one of the best cryptocurrencies by reputation, Cardano has been underperforming recently and its relative strength index (RSI) of 38.510 is not very optimistic. It’s an uphill battle between the bearers and the bulls, and ADA investors have moved on to other projects achieving 100% ROI in two months.
Milei Moneda Investors Calculate Profit
Milei Moneda is the new meme coin that has everyone talking about its 100% ROI. Don’t distort it. 100% ROI is not a prediction. The price is fixed and early investors will have the greatest opportunity to double their MEDA investment.
Milei Moneda is offering a massive supply of 500,000,000 MEDA tokens and the cryptocurrency ICO has implemented a deflation system to deal with inflation and ensure that MEDA’s growth is not hindered. 5% of all MEDA tokens are burned after use, creating scarcity and increasing the value of the token.
Milei Moneda investors will also have access to the DAO community of MEDA holders where they can share ideas, participate in community activities, and win prizes.
Milei Moneda’s pre-sale is still in Phase 1 of the MEDA pre-sale. The price is fixed. MEDA is currently selling for $0.010, and you will enjoy 100% ROI when the project launches in May at $0.020 per token.
To learn more about this project, visit the Milei Moneda pre-sale website or join the community.
Disclosure: This content is provided by a third party. crypto.news does not endorse any products mentioned on this page. Users must conduct their own investigation before taking any action related to the Company.